Can a THC-Based drug calm Alzheimer's agitation? new trial aims to find out
Symptom relief
Not yet recruiting
This study tests whether dronabinol, a synthetic form of THC (the active ingredient in cannabis), can safely reduce agitation in people with Alzheimer's disease. About 140 adults aged 50 to 90 with Alzheimer's-related agitation will receive either dronabinol or a placebo for 12 w…
Phase: PHASE2, PHASE3 • Sponsor: Benuvia Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC